Choice of first antihypertensive: simple as ABCD?

Area of Science:

• Cardiology
• Pharmacology
• Hypertension Management

Background:

• Current British Hypertension Society guidelines suggest age influences antihypertensive drug response.
• Guidelines recommend angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) or beta-blockers (A/B) for <55 years.
• Guidelines recommend calcium channel blockers (CCBs) or diuretics (C/D) for >=55 years.

Purpose of the Study:

• To investigate the efficacy of age-based antihypertensive drug selection.
• To determine if the age threshold of 55 years accurately predicts treatment response.
• To evaluate the effectiveness of A/B versus C/D drug classes based on patient age.

Main Methods:

• A cohort study of 175 untreated hypertensive white patients (aged 19-80 years) was conducted.
• Patients were randomized to either A/B or C/D antihypertensive agents.
• Blood pressure was measured at baseline and after 4 weeks of therapy in a single-blind manner.

Main Results:

• No significant difference in baseline blood pressure between groups.
• A/B drugs showed greater BP reduction in younger patients (<55 years) compared to older patients (>=55 years).
• C/D drugs were not more effective than A/B drugs in patients aged >=55 years.

Conclusions:

• The age of 55 years is an arbitrary and unsupported threshold for selecting antihypertensive agents in white hypertensive populations.
• Current guideline recommendations regarding age as a determinant for antihypertensive drug choice require further investigation.
• A prospective, multicenter study is needed to refine guidelines for age-specific antihypertensive therapy.